JACKSONVILLE, Fla.--(BUSINESS WIRE)--Espero Pharmaceuticals, Inc., (http://www.esperopharma.com) a privately held specialty pharmaceutical company, today announced the signing of an exclusive Licensing and Distribution Agreement with G. Pohl-Boskamp GmbH & Co. KG (“Pohl-Boskamp”), a fully-integrated German pharmaceutical company with a 175 year operating history, for its new nitroglycerin sublingual powder formulation for acute relief of an attack or prophylaxis of angina pectoris for the U.S. market.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
